Answers are grounded in this paper and cite their sources.
Daily administration of 1 mg of folinic acid to immunosuppressed rats with incipient or established Pneumocystis carinii pneumonia did not impair the capacity of trimethoprim-sulfamethoxazole to either prevent or treat this disease. These observations constitute the first experimental support for the use of folinic acid to prevent or control cytopenias that occur in patients with Pneumocystis carinii pneumonia who are under trimethoprim-sulfamethoxazole treatment.
No takes yet. Share an insight, caveat, or question.
D'Antonio et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: